Medpace Holdings Inc vs Prologis Inc — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Prologis Inc trades at $151.05 (market cap $137.50B). The key difference: Prologis Inc is far larger — about 9.1× Medpace Holdings Inc's market cap, and Prologis Inc pays a 2.9% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | PLD | |
|---|---|---|
Market Cap | $15.08B | $137.50B |
Sector | Technology | Real Estate |
52-Week High | $620.59 | $149.96 |
52-Week Low | $308.88 | $104.08 |
Enterprise Value | $14.55B | $172.18B |
Dividend Yield | — | 2.9% |
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →